Age-dependent tissue expression patterns of Sirt1 in senescence-accelerated mice

Molecular Medicine Reports

Volumn 10, Issue 6, 2014, Pages 3296-3302

  Gong, Huan ^a   Pang, Jing ^a   Han, Yiwen ^a   Dai, Yang ^a   Dai, Dapeng ^a   Cai, Jianping ^a   Zhang, Tie Mei ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

Aging; Brain; Liver; Senescence accelerated mouse; Sirtuin 1; Skeletal muscle; White adipose tissues

Indexed keywords

MUS;

MESSENGER RNA; SIRT1 PROTEIN, MOUSE; SIRTUIN 1;

AGING; ANIMAL; BRAIN; CELL AGING; DEGENERATIVE DISEASE; GENETIC TRANSCRIPTION; GENETICS; LIVER; MALE; METABOLISM; MOUSE; PROTEIN SYNTHESIS; SKELETAL MUSCLE;

AGING; ANIMALS; BRAIN; CELL AGING; LIVER; MALE; MICE; MUSCLE, SKELETAL; NEURODEGENERATIVE DISEASES; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; SIRTUIN 1; TRANSCRIPTION, GENETIC;

EID: 84914145498     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2648     Document Type: Article

References (29)

1. Tissenbaum HA and Guarente L: Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410: 227-230, 2001.
2. Viswanathan M and Guarente L: Regulation of Caenorhabditis elegans lifespan by sir-2-1 transgenes. Nature 477: E1-E2, 2011.
3. Donmez G and Guarente L: Aging and disease: connections to sirtuins. Aging Cell 9: 285-290, 2010.
4. Guarente L: Franklin H. Epstein Lecture: Sirtuins, aging, and medicine. N Engl J Med 364: 2235-2244, 2011.
5. Imai S, Armstrong CM, Kaeberlein M and Guarente L: Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403: 795-800, 2000.
6. Yamamoto H, Schoonjans K and Auwerx J: Sirtuin functions in health and disease. Mol Endocrinol 21: 1745-1755, 2007.
7. Banks AS, Kon N, Knight C, et al: SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab 8: 333-341, 2008.
8. Bordone L, Cohen D, Robinson A, et al: SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 6: 759-767, 2007.
9. Herranz D, Muñoz-Martin M, Cañamero M, et al: Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat Commun 1: 3, 2010.
10. Cheng HL, Mostoslavsky R, Saito S, et al: Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 100: 10794-10799, 2003.
11. McBurney MW, Yang X, Jardine K, Bieman M, Th'ng J and Lemieux M: The absence of SIR2alpha protein has no effect on global gene silencing in mouse embryonic stem cells. Mol Cancer Res 1: 402-409, 2003.
12. Takeda T, Hosokawa M, Takeshita S, et al: A new murine model of accelerated senescence. Mech Ageing Dev 17: 183-194, 1981.
13. Flood JF and Morley JE: Learning and memory in the SAMP8 mouse. Neurosci Biobehav Rev 22: 1-20, 1998.
14. Campbell KH and O'Hare AM: Kidney disease in the elderly: update on recent literature. Curr Opin Nephrol Hypertens 17: 298-303, 2008.
15. O'Hare AM, Bertenthal D, Covinsky KE, et al: Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol 17: 846-853, 2006.
16. Lim JH, Kim EN, Kim MY, et al: Age-associated molecular changes in the kidney in aged mice. Oxid Med Cell Longev 2012: 171383, 2012.
17. Sasaki T, Maier B, Bartke A and Scrable H: Progressive loss of SIRT1 with cell cycle withdrawal. Aging Cell 5: 413-422, 2006.
18. Mortuza R, Chen S, Feng B, Sen S and Chakrabarti S: High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS One 8: e54514, 2013.
19. Miyamoto M: Characteristics of age-related behavioral changes in senescence-accelerated mouse SAMP8 and SAMP10. Exp Gerontol 32: 139-148, 1997.
20. Powers DC, Morley JE and Flood JF: Age-related changes in LFA-1 expression, cell adhesion, and PHA-induced proliferation by lymphocytes from senescence-accelerated mouse (SAM)-P/8 and SAM-R/1 substrains. Cell Immunol 141: 444-456, 1992.
21. Morley JE: The SAMP8 mouse: a model of Alzheimer disease? Biogerontology 3: 57-60, 2002.
22. Morley JE, Armbrecht HJ, Farr SA and Kumar VB: The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease. Biochim Biophys Acta 1822: 650-656, 2012.
23. Asher G, Gatfield D, Stratmann M, et al: SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 134: 317-328, 2008.
24. Belden WJ and Dunlap JC: SIRT1 is a circadian deacetylase for core clock components. Cell 134: 212-214, 2008.
25. Salminen A, Kauppinen A, Suuronen T and Kaarniranta K: SIRT1 longevity factor suppresses NF-kappaB -driven immune responses: regulation of aging via NF-kappaB acetylation? Bioessays 30: 939-942, 2008.
26. Sequeira J, Boily G, Bazinet S, et al: sirt1-null mice develop an autoimmune-like condition. Exp Cell Res 314: 3069-3074, 2008.
27. Chong ZZ, Shang YC, Wang S and Maiese K: SIRT1: new avenues of discovery for disorders of oxidative stress. Expert Opin Ther Targets 16: 167-178, 2012.
28. Qin W, Yang T, Ho L, et al: Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281: 21745-21754, 2006.
29. Kim D, Nguyen MD, Dobbin MM, et al: SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26: 3169-3179, 2007.